Paper Details
- Home
- Paper Details
Sunitinib-induced oxidative imbalance and retinotoxic effects in rats.
Author: AndréHelder, AramburuÓscar, MateAlfonso, Reyes-GoyaClaudia, Santana-GarridoÁlvaro, VázquezCarmen M
Original Abstract of the Article :
Sunitinib (Su), a tyrosine kinase inhibitor, is one of the most commonly used anti-angiogenic drugs. Some studies have described retinal detachment and photoreceptor damage following systemic exposure to Su, despite beneficial effects achieved with local treatment of ocular pathologies. The aim of t...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/j.lfs.2020.118072
データ提供:米国国立医学図書館(NLM)
Sunitinib: A Double-Edged Sword in Cancer Treatment
Imagine a desert traveler who discovers a powerful elixir that can cure a deadly disease, but also comes with unexpected side effects. This research explores the complexities of sunitinib, a tyrosine kinase inhibitor used to treat various cancers, including kidney cancer.
Sunitinib and Retinal Toxicity
The study focuses on the potential retinal toxicity of sunitinib, a significant concern given its widespread use. The researchers investigated the role of oxidative stress in the development of retinal damage following sunitinib treatment.
Understanding the Mechanisms of Retinal Toxicity
The study suggests that sunitinib can induce oxidative imbalance in the retina, leading to retinal damage. This finding highlights the importance of monitoring for retinal toxicity in patients receiving sunitinib treatment.
Dr. Camel's Conclusion
This research reminds us that even powerful cancer treatments can have unintended consequences. Just as a desert traveler must weigh the risks and benefits of each path, we must carefully consider the potential side effects of cancer drugs while striving to achieve the best outcomes for our patients.
Date :
- Date Completed 2020-09-16
- Date Revised 2020-09-16
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.